JULIANA ESCUDERO: Open Payments
NPI 1255902946 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 15 payments from 10 companies in 2025. Trend: 2023 $668 · 2024 $190 · 2025 $553
Food & beverage: $453Education: $100
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $152 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| ABBVIE INC. | 4 | $81 |
| GENZYME CORPORATION | 1 | $79 |
| Incyte Corporation | 2 | $56 |
| Janssen Biotech, Inc. | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $16 |
| Amgen Inc. | 1 | $16 |
Products named: DUPIXENT, SKYRIZI, OPZELURA, TREMFYA, NEMLUVIO, CIBINQO, BLU-U, OTEZLA.
Industry payments across FL — which companies pay providers there.
